Translate the text from Welsh to English.



 
Heddiw, rwyf fi, ynghyd â’m Gweinidogion cyfatebol ar draws pedair gwlad y DU, wedi cytuno i dderbyn a gweithredu’r argymhellion a wnaed gan y Pwyllgor Cynghori ar Ddiogelwch Gwaed, Meinweoedd ac Organau (SaBTO) mewn perthynas â chyflwyno sgrinio serolegol cyffredinol i ganfod y feirws herpes sy’n gysylltiedig â sarcoma Kaposi (KSHV) mewn rhoddwyr organau sydd wedi marw.


Ers 2015, mae Gwaed a Thrawsblaniadau’r GIG wedi ymchwilio i nifer o ddigwyddiadau wedi i glefyd KSHV ddatblygu yn y rhai a oedd wedi cael trawsblaniadau organau solet yn y DU. Gelwir KSHV hefyd yn haint y feirws herpes dynol math 8 (HHV\-8\). Haint asymptomatig yw hwn gan mwyaf, sy’n gallu datblygu’n heintiau a chlefydau amrywiol eraill mewn cleifion.


Er nad yw nifer gwirioneddol yr achosion o haint KSHV sy’n deillio o roddwyr organau neu a gafwyd yn fuan ar ôl trawsblannu yn hysbys, mae difrifoldeb y clefyd a ddisgrifiwyd dros y blynyddoedd wedi dangos bod angen gweithredu.


Rwyf wedi cyfarwyddo Gwaed a Thrawsblaniadau’r GIG i weithredu profion HHV\-8 ar bob rhoddwr organau sydd wedi marw. Bydd y costau sy’n gysylltiedig â chyflwyno’r profion hyn yn cael eu talu o’i ddyraniad cyllid. Rwy’n disgwyl i brofion gael eu cyflwyno cyn gynted ag sy’n ymarferol bosibl, ac rwy’n deall bod gwaith paratoi wedi dechrau eisoes yn y cyswllt hwnnw.


Bydd y gwaith hwn yn canolbwyntio ar osgoi marwolaethau ymysg y rhai sydd wedi cael trawsblaniad a gaiff eu hachosi gan heintiau KSHV neu HHV\-8 cychwynnol sy’n deillio o roddwyr organau; a gwella diogelwch trawsblannu organau yng Nghymru a gweddill y DU.


Mae’r gwelliannau hyn hefyd yn cyd\-fynd â’r nodau a amlinellir yn Organ Donation and Transplantation 2030: Meeting the Need (Saesneg yn Unig), sy’n cyflwyno gweledigaeth 10 mlynedd ynghylch rhoi a thrawsblannu organau yn y DU.







Translation:


 
Today, along with my counterparts across all four UK nations, I have agreed to accept and implement the recommendations made by the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) in relation to introducing universal serological screening of deceased organ donors for kaposi sarcoma associated herpes virus (KSHV).


Since 2015, NHS Blood and Transplant has investigated multiple incidents prompted by the development of KSHV disease in recipients of solid organ transplants in the UK. KSHV is also known as human herpes virus type 8 (HHV\-8\) infection and is a mostly asymptomatic infection, which can develop into various other infections and diseases in patients.


While the true incidence of donor\-derived or newly\-acquired post\-transplant KSHV infection is not known, the severity of disease described over the years has indicated that action is necessary.


I have instructed NHS Blood and Transplant to implement HHV\-8 testing on all deceased organ donors. The costs associated with the introduction of this testing will be met from within its funding allocation. I expect testing to be introduced as soon as practically possible and understand preparatory work has already started.


This work will focus on averting transplantation recipient deaths due to donor\-derived primary KSHV or HHV8 infections and improve the safety of organ transplantation in Wales and the rest of the UK.


These improvements also align themselves with the aims set out in Organ Donation and Transplantation 2030: Meeting the Need, which sets out a 10\-year vision for organ donation and transplantation in the UK.